Detecting and Managing Insulin Resistance
Harnessing Advances for Improving Exome
The Power of Pharmacogenomics in Clinical Practice
Give Us Your Feedback
Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia.